CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 26.36
  • +0.60+2.33%
Market Closed Aug 30 15:00 CST
9.67BMarket Cap-12469P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-21.52%2.62B
6,540.35%2.76B
5,769.30%2.89B
--3.01B
12,952.94%3.34B
--41.54M
248.34%49.28M
----
--25.62M
-66.70%14.15M
Transactional financial assets
----
----
-88.33%27.71M
--33.04M
-77.91%83.82M
--164.26M
-44.43%237.36M
----
--379.4M
2,998.54%427.11M
Notes receivable and accounts receivable
-57.66%12.03K
-94.39%6.01K
----
----
-94.13%28.41K
--107.12K
----
----
--483.95K
----
-Accounts receivable
-57.66%12.03K
-94.39%6.01K
----
----
-94.13%28.41K
--107.12K
----
----
--483.95K
----
Other receivables (including interest and dividends)
18.61%3.15M
-6.91%3.14M
15.50%2.84M
--2.77M
-11.89%2.65M
--3.37M
60.50%2.46M
----
--3.01M
-58.21%1.53M
-Other receivable
18.61%3.15M
----
15.50%2.84M
----
-11.89%2.65M
--3.37M
60.50%2.46M
----
--3.01M
-58.21%1.53M
Advance payment
-14.56%33.16M
13.25%39.32M
-35.09%18.98M
--31.89M
42.21%38.81M
--34.72M
30.21%29.23M
----
--27.29M
10.39%22.45M
Inventories
20.49%59.72M
11.87%59.89M
-1.55%55.45M
--61.09M
-2.00%49.56M
--53.53M
67.34%56.33M
----
--50.57M
112.36%33.66M
Other current assets
143.95%45.04M
22.20%39.45M
42.75%34.75M
--25.89M
302.80%18.46M
--32.29M
-19.67%24.34M
----
--4.58M
201.84%30.3M
Total current assets
-21.83%2.77B
779.26%2.9B
659.87%3.03B
--3.16B
620.54%3.54B
--329.82M
-24.60%399M
----
--490.96M
395.56%529.2M
Non Current assets
Investment real estate
-2.30%370.72K
-2.29%372.9K
-2.27%375.08K
--377.27K
-2.25%379.45K
--381.63K
-2.22%383.81K
----
--388.17K
-2.17%392.53K
Fixed assets
40.90%387.77M
----
41.76%405.26M
----
-7.34%275.21M
--281.25M
3.74%285.88M
----
--297M
6.61%275.57M
Constru in process
-73.45%50.03M
----
-68.34%52.18M
----
708.95%188.48M
--176.93M
802.35%164.82M
----
--23.3M
96.06%18.27M
Intangible assets
-5.45%42.16M
-5.53%42.68M
-3.40%43.54M
--44.38M
-2.94%44.59M
--45.17M
-1.83%45.08M
----
--45.94M
-6.18%45.92M
Long deferred expense
-13.02%25.53M
-12.17%26.73M
9.47%27.92M
--28.2M
6.70%29.35M
--30.43M
8.48%25.51M
----
--27.51M
-5.82%23.51M
Usufruct assets
-10.18%29.96M
-12.03%31.58M
-17.99%30.39M
--30.81M
-20.48%33.36M
--35.9M
9.00%37.05M
----
--41.95M
--33.99M
Other non current assets
17.31%5.47M
-33.15%1.4M
-29.83%3.08M
--3.79M
-89.58%4.67M
--2.09M
-94.22%4.39M
----
--44.76M
54.16%75.97M
Total non current assets
-6.03%541.3M
-3.62%551.46M
-0.07%562.74M
--571.19M
19.80%576.04M
--572.16M
18.90%563.11M
----
--480.85M
21.01%473.61M
Total assets
-19.61%3.31B
282.65%3.45B
273.62%3.59B
285.57%3.74B
323.29%4.11B
--901.98M
-4.06%962.11M
--968.9M
--971.81M
101.30%1B
Liabilities
Current liabilities
Short term loan
--630.54K
--630.59K
--630.59K
----
----
----
----
----
----
----
Notes payable and accounts payable
25.12%83.82M
6.79%77.32M
22.40%83.04M
--77.04M
26.04%66.99M
--72.4M
45.55%67.84M
----
--53.15M
39.92%46.61M
-Accounts payable
25.12%83.82M
6.79%77.32M
22.40%83.04M
--77.04M
26.04%66.99M
--72.4M
45.55%67.84M
----
--53.15M
39.92%46.61M
Advance receipts
----
----
----
--6.33K
--12.66K
----
----
----
----
----
Salaries payable
72.76%25.65M
63.65%22.77M
59.80%34.44M
--16.02M
30.77%14.85M
--13.92M
35.99%21.55M
----
--11.35M
20.47%15.85M
Taxs payable
-71.90%318.61K
21.98%850.14K
-73.65%1.71M
--1.7M
597.45%1.13M
--696.94K
-1.26%6.5M
----
--162.55K
3,092.85%6.59M
Other payable (including interest and dividends)
-56.52%10.76M
-12.61%6.94M
-6.28%6.99M
--6.82M
279.11%24.75M
--7.94M
35.12%7.46M
----
--6.53M
-98.71%5.52M
-Interest payable
----
----
----
--760.12K
23.90%1.07M
--1.12M
36.52%1.1M
----
--862.68K
50.98%805.36K
-Other payable
-54.55%10.76M
----
9.93%6.99M
----
317.98%23.68M
--6.83M
34.89%6.36M
----
--5.67M
-98.90%4.71M
Non current liabilities due within one year
-61.84%13.7M
-45.59%11.54M
-56.27%10.07M
--9.16M
118.02%35.91M
--21.21M
101.03%23.02M
----
--16.47M
203.29%11.45M
Total current liabilities
-6.10%134.88M
3.35%120.05M
8.31%136.87M
--110.76M
63.85%143.64M
--116.16M
46.92%126.37M
----
--87.66M
-82.08%86.01M
Current liabilities
Long term account payable
----
----
----
----
----
----
----
----
--5.33M
-46.55%5.08M
Long term deferred income
15.52%41.66M
15.60%42.43M
14.60%43.2M
--35.43M
-24.71%36.07M
--36.71M
6.03%37.69M
----
--47.9M
4.10%35.55M
Lease liabilities
-27.86%18.47M
-26.20%21.66M
-28.16%21.82M
--23.61M
-27.06%25.6M
--29.35M
6.01%30.37M
----
--35.11M
--28.65M
Total non current liabilities
-24.41%673.01M
-22.57%672.55M
-16.51%673.49M
--666.68M
22.56%890.31M
--868.58M
33.37%806.66M
----
--726.44M
53.77%604.83M
Total liabilities
-21.86%807.89M
-19.51%792.6M
-13.15%810.36M
-14.41%777.43M
27.00%1.03B
--984.74M
35.06%933.03M
--908.29M
--814.1M
-20.89%690.84M
Shareholders equity
Paid-in capital
0.00%366.68M
33.34%366.68M
33.34%366.68M
--366.68M
33.34%366.68M
--275M
0.00%275M
----
--275M
37.50%275M
Capital reserve funds
4.96%4.11B
515.39%4.08B
604.37%4.04B
--3.98B
923.19%3.92B
--662.41M
104.88%573.29M
----
--383.15M
11.93%279.82M
Retained profit
-64.20%-1.98B
-74.90%-1.78B
-97.82%-1.62B
---1.39B
-141.26%-1.21B
---1.02B
-237.34%-819.21M
----
---500.44M
70.57%-242.84M
Shareholders equity without minority interests
-18.86%2.5B
3,312.43%2.66B
9,473.79%2.78B
4,780.76%2.96B
1,852.79%3.08B
---82.77M
-90.68%29.08M
--60.61M
--157.71M
183.18%311.98M
Total shareholder equity
-18.86%2.5B
3,312.43%2.66B
9,473.79%2.78B
4,780.76%2.96B
1,852.79%3.08B
---82.77M
-90.68%29.08M
--60.61M
--157.71M
183.18%311.98M
Total liabilityies and equity
-19.61%3.31B
282.65%3.45B
273.62%3.59B
285.57%3.74B
323.29%4.11B
--901.98M
-4.06%962.11M
--968.9M
--971.81M
101.30%1B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
--
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -21.52%2.62B6,540.35%2.76B5,769.30%2.89B--3.01B12,952.94%3.34B--41.54M248.34%49.28M------25.62M-66.70%14.15M
Transactional financial assets ---------88.33%27.71M--33.04M-77.91%83.82M--164.26M-44.43%237.36M------379.4M2,998.54%427.11M
Notes receivable and accounts receivable -57.66%12.03K-94.39%6.01K---------94.13%28.41K--107.12K----------483.95K----
-Accounts receivable -57.66%12.03K-94.39%6.01K---------94.13%28.41K--107.12K----------483.95K----
Other receivables (including interest and dividends) 18.61%3.15M-6.91%3.14M15.50%2.84M--2.77M-11.89%2.65M--3.37M60.50%2.46M------3.01M-58.21%1.53M
-Other receivable 18.61%3.15M----15.50%2.84M-----11.89%2.65M--3.37M60.50%2.46M------3.01M-58.21%1.53M
Advance payment -14.56%33.16M13.25%39.32M-35.09%18.98M--31.89M42.21%38.81M--34.72M30.21%29.23M------27.29M10.39%22.45M
Inventories 20.49%59.72M11.87%59.89M-1.55%55.45M--61.09M-2.00%49.56M--53.53M67.34%56.33M------50.57M112.36%33.66M
Other current assets 143.95%45.04M22.20%39.45M42.75%34.75M--25.89M302.80%18.46M--32.29M-19.67%24.34M------4.58M201.84%30.3M
Total current assets -21.83%2.77B779.26%2.9B659.87%3.03B--3.16B620.54%3.54B--329.82M-24.60%399M------490.96M395.56%529.2M
Non Current assets
Investment real estate -2.30%370.72K-2.29%372.9K-2.27%375.08K--377.27K-2.25%379.45K--381.63K-2.22%383.81K------388.17K-2.17%392.53K
Fixed assets 40.90%387.77M----41.76%405.26M-----7.34%275.21M--281.25M3.74%285.88M------297M6.61%275.57M
Constru in process -73.45%50.03M-----68.34%52.18M----708.95%188.48M--176.93M802.35%164.82M------23.3M96.06%18.27M
Intangible assets -5.45%42.16M-5.53%42.68M-3.40%43.54M--44.38M-2.94%44.59M--45.17M-1.83%45.08M------45.94M-6.18%45.92M
Long deferred expense -13.02%25.53M-12.17%26.73M9.47%27.92M--28.2M6.70%29.35M--30.43M8.48%25.51M------27.51M-5.82%23.51M
Usufruct assets -10.18%29.96M-12.03%31.58M-17.99%30.39M--30.81M-20.48%33.36M--35.9M9.00%37.05M------41.95M--33.99M
Other non current assets 17.31%5.47M-33.15%1.4M-29.83%3.08M--3.79M-89.58%4.67M--2.09M-94.22%4.39M------44.76M54.16%75.97M
Total non current assets -6.03%541.3M-3.62%551.46M-0.07%562.74M--571.19M19.80%576.04M--572.16M18.90%563.11M------480.85M21.01%473.61M
Total assets -19.61%3.31B282.65%3.45B273.62%3.59B285.57%3.74B323.29%4.11B--901.98M-4.06%962.11M--968.9M--971.81M101.30%1B
Liabilities
Current liabilities
Short term loan --630.54K--630.59K--630.59K----------------------------
Notes payable and accounts payable 25.12%83.82M6.79%77.32M22.40%83.04M--77.04M26.04%66.99M--72.4M45.55%67.84M------53.15M39.92%46.61M
-Accounts payable 25.12%83.82M6.79%77.32M22.40%83.04M--77.04M26.04%66.99M--72.4M45.55%67.84M------53.15M39.92%46.61M
Advance receipts --------------6.33K--12.66K--------------------
Salaries payable 72.76%25.65M63.65%22.77M59.80%34.44M--16.02M30.77%14.85M--13.92M35.99%21.55M------11.35M20.47%15.85M
Taxs payable -71.90%318.61K21.98%850.14K-73.65%1.71M--1.7M597.45%1.13M--696.94K-1.26%6.5M------162.55K3,092.85%6.59M
Other payable (including interest and dividends) -56.52%10.76M-12.61%6.94M-6.28%6.99M--6.82M279.11%24.75M--7.94M35.12%7.46M------6.53M-98.71%5.52M
-Interest payable --------------760.12K23.90%1.07M--1.12M36.52%1.1M------862.68K50.98%805.36K
-Other payable -54.55%10.76M----9.93%6.99M----317.98%23.68M--6.83M34.89%6.36M------5.67M-98.90%4.71M
Non current liabilities due within one year -61.84%13.7M-45.59%11.54M-56.27%10.07M--9.16M118.02%35.91M--21.21M101.03%23.02M------16.47M203.29%11.45M
Total current liabilities -6.10%134.88M3.35%120.05M8.31%136.87M--110.76M63.85%143.64M--116.16M46.92%126.37M------87.66M-82.08%86.01M
Current liabilities
Long term account payable ----------------------------------5.33M-46.55%5.08M
Long term deferred income 15.52%41.66M15.60%42.43M14.60%43.2M--35.43M-24.71%36.07M--36.71M6.03%37.69M------47.9M4.10%35.55M
Lease liabilities -27.86%18.47M-26.20%21.66M-28.16%21.82M--23.61M-27.06%25.6M--29.35M6.01%30.37M------35.11M--28.65M
Total non current liabilities -24.41%673.01M-22.57%672.55M-16.51%673.49M--666.68M22.56%890.31M--868.58M33.37%806.66M------726.44M53.77%604.83M
Total liabilities -21.86%807.89M-19.51%792.6M-13.15%810.36M-14.41%777.43M27.00%1.03B--984.74M35.06%933.03M--908.29M--814.1M-20.89%690.84M
Shareholders equity
Paid-in capital 0.00%366.68M33.34%366.68M33.34%366.68M--366.68M33.34%366.68M--275M0.00%275M------275M37.50%275M
Capital reserve funds 4.96%4.11B515.39%4.08B604.37%4.04B--3.98B923.19%3.92B--662.41M104.88%573.29M------383.15M11.93%279.82M
Retained profit -64.20%-1.98B-74.90%-1.78B-97.82%-1.62B---1.39B-141.26%-1.21B---1.02B-237.34%-819.21M-------500.44M70.57%-242.84M
Shareholders equity without minority interests -18.86%2.5B3,312.43%2.66B9,473.79%2.78B4,780.76%2.96B1,852.79%3.08B---82.77M-90.68%29.08M--60.61M--157.71M183.18%311.98M
Total shareholder equity -18.86%2.5B3,312.43%2.66B9,473.79%2.78B4,780.76%2.96B1,852.79%3.08B---82.77M-90.68%29.08M--60.61M--157.71M183.18%311.98M
Total liabilityies and equity -19.61%3.31B282.65%3.45B273.62%3.59B285.57%3.74B323.29%4.11B--901.98M-4.06%962.11M--968.9M--971.81M101.30%1B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion--------------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg